CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
35,604,156
Share change
+1,744,623
Total reported value
$89,681,592
Put/Call ratio
90%
Price per share
$2.52
Number of holders
77
Value change
+$4,372,606
Number of buys
35
Number of sells
18

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2017

As of 30 Sep 2017, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,604,156 shares. The largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, venBio Select Advisor LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, KENNEDY CAPITAL MANAGEMENT, INC., NORTHERN TRUST CORP, and AJO, LP. This page lists 77 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
68
Q3 2017 holders
77
Holder diff
9
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.